Agenus (AGEN) Share-based Compensation (2010 - 2026)
Agenus' (AGEN) quarterly Share-based Compensation came in at $2.0 million in Q1 2026, down 39.99% year-on-year from $3.3 million in Q1 2025, and up 26.02% quarter-over-quarter from $1.6 million in Q4 2025.
Agenus (AGEN) Share-based Compensation (2010 - 2026) Analysis & Trends
Agenus' Share-based Compensation history runs 17 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- On a quarterly basis, Share-based Compensation fell 39.99% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $2.0 million, a 92.44% decrease from a year earlier, with the FY2025 full-year figure at $11.9 million, down 56.47% from the prior year.
- Share-based Compensation climbed to $2.0 million in Q1 2026 per AGEN's latest filing, from $1.6 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $9.3 million in Q2 2024 and bottomed at $1.6 million in Q4 2025.
- The 5-year median for Share-based Compensation is $4.8 million (2025), against an average of $5.2 million.
- Across the five-year window, Share-based Compensation soared 347.22% in 2022 and tumbled 65.2% in 2025, its largest moves.
- Year by year, Share-based Compensation stood at $9.2 million in 2022, then slumped by 40.57% to $5.5 million in 2023, then slipped by 16.48% to $4.6 million in 2024, then tumbled by 65.2% to $1.6 million in 2025, then climbed by 26.02% to $2.0 million in 2026.
- Per Business Quant, the three latest AGEN Share-based Compensation figures stand at $2.0 million (Q1 2026), $1.6 million (Q4 2025), and $4.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 1.59 Mn |
| Dec 31, 2025 | 1.59 Mn |
| Sep 30, 2025 | 4.80 Mn |
| Sep 30, 2025 | 4.80 Mn |
| Jun 30, 2025 | 3.44 Mn |
| Jun 30, 2025 | 3.44 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Dec 31, 2024 | 4.56 Mn |
| Dec 31, 2024 | 4.56 Mn |
| Sep 30, 2024 | 9.28 Mn |
| Sep 30, 2024 | 9.28 Mn |
| Jun 30, 2024 | 9.29 Mn |
| Jun 30, 2024 | 9.29 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Dec 31, 2023 | 5.46 Mn |
| Dec 31, 2023 | 5.46 Mn |